INDUSTRY × Interventional × Ovarian Neoplasms × Clear all
NCT07623369 2026-06-03

A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors

Huahui Health

Phase 1 Not yet recruiting
56 enrolled
NCT02568267 2026-05-27

STARTRK-2

Hoffmann-La Roche

Phase 2 Active not recruiting
534 enrolled 1 FDA